Curi RMB Capital’s Cantel Medical Corporation CMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-23,307
Closed -$1.56M 854
2019
Q1
$1.56M Sell
23,307
-34,557
-60% -$2.62M 0.04% 387
2018
Q4
$4.31M Buy
57,864
+6,186
+12% +$511K 0.11% 206
2018
Q3
$4.76M Sell
51,678
-3,733
-7% -$356K 0.11% 216
2018
Q2
$5.45M Sell
55,411
-22,700
-29% -$2.54M 0.13% 198
2018
Q1
$8.7M Sell
78,111
-16,435
-17% -$1.84M 0.22% 132
2017
Q4
$9.73M Sell
94,546
-10,479
-10% -$1.04M 0.25% 110
2017
Q3
$9.89M Sell
105,025
-33,838
-24% -$2.67M 0.26% 121
2017
Q2
$10.8M Buy
+138,863
New +$10.4M 0.31% 96

Other funds holding CMD

Curi RMB Capital's CMD Position: Q2 2019 in Review

Curi RMB Capital sold out of Cantel Medical Corporation (CMD) in Q2 2019, closing a stake of 23,307 shares — an estimated $1.56M sold.

Curi RMB Capital first reported a position in CMD in Q2 2017 and held it in 8 quarters. The position peaked at $10.8M in Q2 2017. 242 funds tracked by Wall St. Rank hold CMD as of Q2 2019.

  • Curi RMB Capital reported no remaining Cantel Medical Corporation position as of Q2 2019 after selling out during the quarter.
  • Curi RMB Capital sold 23,307 Cantel Medical Corporation shares in Q2 2019, an estimated $1.56M.
  • Curi RMB Capital first reported a position in Cantel Medical Corporation in Q2 2017 and held it in 8 quarters.
  • Curi RMB Capital's Cantel Medical Corporation position peaked at $10.8M in Q2 2017.
  • 242 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2019.

Based on Curi RMB Capital's 13F filing for Q2 2019, filed 13 Aug 2019.